《復牌表現》亞洲能源物流(00351.HK)由低位急彈45%曾越20天線 獲第三方入主
亞洲能源物流(00351.HK)獲第三方入主,該股今早復牌由上市低位急彈曾重越10天及20天線(0.2元及0.255元),最高見0.265元,現造0.24元,急彈45%,但一向薄弱成交僅增至235萬股。
亞洲能源物流公布,擬向獨立第三方彭越發行11億股新股及本金額4,800萬元3年期零息可換股債券(CB),發行價及換股價均為0.16元(較停牌前折讓3.03%),集資總額2.24億元,擬用於償還2021年到期CB及進一步收購船舶及潛在業務發展等。完成後,彭氏將持有公司股本68.92%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.